Navigation Links
SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
Date:1/3/2012

WASHINGTON, LONDON and HONG KONG, Jan. 3, 2012 /PRNewswire/ -- SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, announced that Neil J. Campbell, President and CEO, will present a corporate and technology overview at Biotech Showcase 2012 in San Francisco, CA.  Mr. Campbell's presentation is scheduled for Monday, January 9, 2012 at 4:45pm in the Stockton Room at the Parc 55 Wyndham Union Square Hotel.

The presentation will include an overview of SuperNova's proprietary point-of-care (POC) and point-of-use (POU) diagnostic technology, targeted for four industry sectors: human health, animal health, industrial and biodefense / biosecurity; as well as provide additional details on the company's recent commercial partnership with Concile, GmbH.

"Biotech Showcase is the premier event for investors and business leaders in the healthcare industry, and is an ideal opportunity for SuperNova to feature its 'lab-in-the-palm-of-your-hand' diagnostic system," said Mr. Campbell.  "With our AmpCrystal® platform, which provides an array of diagnostic capabilities at point of interest settings in human and non-human applications as well as improving central laboratory assays, SuperNova is well poised to capture the multi-billion dollar point-of-care and general diagnostic markets." 

About SuperNova Diagnostics®, Inc.
SuperNova® is a development-stage diagnostics company with a proprietary platform for conducting diagnostics at the site of interest with point-of-care in human health and point-of-use for non-human health applications.  A powerful proprietary nanochemistry, AmpCrystal®, can deliver novel, next generation performance for pathogens, proteins, and directly measure DNA without PCR with ultra-low sensitivity and specificity while not sacrificing a dynamic range of measurements.  SuperNova can be utilized in a wide range of diagnostic formats (lateral flow, self-contained cartridges, microtitre, microarrays, closed systems, research products and OEM). SuperNova® — Putting the Laboratory in the Palm of Your Hand®.  For additional information, please visit www.supernovadiagnostics.com.

Contacts:
Tiberend Strategic Advisors, Inc.
Jason Rando / June Gregg
(212) 827-0020
jrando@tiberend.com / jgregg@tiberend.com


'/>"/>
SOURCE SuperNova Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
2. SuperNova Diagnostics® to Present at AdvaMed 2011: The Medtech Conference in Washington, D.C.
3. SuperNova Diagnostics® Selected to Present at Launch: Silicon Valley 2011
4. SuperNova Diagnostics® Announces Agreement with KSB Diagnostics of China to Commercialise Neopterin Diagnostics
5. Quest Diagnostics® Care360™ EHR Receives ONC-ATCB 2011/2012 Certification
6. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
7. ShangPharma to Present at J.P. Morgans 30th Annual Healthcare Conference
8. Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)
9. Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting
10. Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society
11. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2019)... , ... January 22, 2019 , ... ... each trial has its own set of assumptions, and RFP creation and management ... evaluating bids is like comparing apples to oranges. These challenges can ultimately lead ...
(Date:1/20/2019)... ... January 17, 2019 , ... ... until recently, the exclusive purview of physicians. That's changing as many services now ... to consumer (DTC) laboratory testing market totaled $208 million in 2018, according to ...
(Date:1/15/2019)... ... January 15, 2019 , ... Personalized treatment plans may extend life ... according to a new study published in the journal Radiology. , Kidney, or ... partial nephrectomy, a surgical procedure in which the tumor and part of the kidney ...
(Date:1/10/2019)... ... , ... Rascal was adopted from a local shelter when he was around two years old. ... just six weeks after he was adopted, he tore his right cruciate ligament. Though ... joint after such a traumatic injury. , Sure enough, when Rascal was about nine years ...
Breaking Biology Technology:
(Date:1/20/2019)... ... 17, 2019 , ... The possibility that ethnic differences exist ... for many years. These observed differences may be manifest in alterations in safety, ... residing in different geographic regions. This created the perceived necessity to fully and ...
(Date:1/14/2019)... Calif. (PRWEB) , ... January 14, 2019 , ... ... proprietary technology to detect precancer and cancer cells in blood, will present new ... significant advancement in the fight against colorectal cancer. The results from this study ...
(Date:1/10/2019)... Va. (PRWEB) , ... January 09, 2019 , ... Dr. ... Ottawa Heart Institute in Ottawa, Ontario, Canada. He is also Director of its ... Department of Medicine, in the Department of Radiology, and in the Department of Cellular ...
Breaking Biology News(10 mins):